Watchlist Price Alert

DaVita Inc. (DVA)

NYSE: DVA · Real-Time Price · USD

136.68

-1.16 (-0.84%)

At close: Jun 17, 2025, 3:59 PM

136.51

-0.12%

After-hours: Jun 17, 2025, 05:47 PM EDT

-0.84% (1D)

Bid	135
Market Cap	10.32B
Revenue (ttm)	12.97B
Net Income (ttm)	859.61M
EPS (ttm)	10.09
PE Ratio (ttm)	13.55
Forward PE	10.58
Analyst	Hold

Ask	138.29
Volume	614,307
Avg. Volume (20D)	812,985
Open	136.58
Previous Close	137.84
Day's Range	135.79 - 137.47
52-Week Range	131.76 - 179.60
Beta	1.11

About DVA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DVA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DVA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

DaVita Inc. is scheduled to release its earnings on Aug 5, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 months ago

-11.09%

DaVita shares are trading lower after the company ... Unlock content with Pro Subscription

4 months ago

+2.94%

DaVita shares are trading lower. The company reported Q4 financial results.

News

1 day ago · zacks.com

DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know

DaVita HealthCare (DVA) reached $137.84 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.

2 weeks ago · zacks.com

Here's Why DaVita HealthCare (DVA) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

3 weeks ago · seekingalpha.com

DaVita: International Expansion And Buybacks Will Boost Returns

International expansion continues with new clinics in Brazil, Ecuador, Chile, and Colombia, supporting long-term growth beyond the US market. DaVita's stock offers a 10% FCF yield, and the share count...

1 month ago · zacks.com

Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

1 month ago · zacks.com

Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

1 month ago · zacks.com

DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract

Strength in revenue per treatment and dialysis patient service revenues drives DVA's first-quarter 2025 performance despite a year-over-year decline in normalized non-acquired treatment.

1 month ago · seekingalpha.com

DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript

DaVita Inc. (NYSE:DVA ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants...

1 month ago · zacks.com

DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates

DaVita HealthCare (DVA) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $2.38 per share a year ago.